bay-k-8644 has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (21.74) | 18.7374 |
| 1990's | 7 (30.43) | 18.2507 |
| 2000's | 7 (30.43) | 29.6817 |
| 2010's | 4 (17.39) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hom, GJ; Rubanyi, GM; Touhey, B | 1 |
| Dong, YJ; Wadsworth, RM | 1 |
| Armstead, WM; Hyman, AL; Kadowitz, PJ; Lippton, HL | 1 |
| Hyman, AL; Kadowitz, PJ; Kriseman, T; McNamara, DB; Underwood, DC | 1 |
| Hyman, AL; Kadowitz, PJ; Lippton, HL | 1 |
| Bellan, JA; Hyman, AL; Kadowitz, PJ; Lippton, HL | 1 |
| Antunes, E; De Nucci, G; Muscará, MN; Ribeiro, MO; Zatz, R | 1 |
| Kalsner, S | 1 |
| Walker, BR | 1 |
| Champion, HC; Kadowitz, PJ | 1 |
| Kawasaki, H | 1 |
| Bivalacqua, TJ; Champion, HC; Kadowitz, PJ; Lambert, DG; McNamara, DB | 1 |
| Arif, AS; Banister, RE; Bivalacqua, TJ; D'Souza, FM; De Witt, BJ; Ibrahim, IN; Kaye, AD; Nossaman, BD | 1 |
| Berg Nyborg, NC; Sheykhzade, M | 1 |
| Heinemann, A; Holzer, P; Peskar, BA; Schuligoi, R; Shahbazian, A | 1 |
| Malvin, GM; Walker, BR | 1 |
| Chang, TH; Wang, HL; Zhang, XH | 1 |
| Badejo, AM; Casey, DB; Dhaliwal, JS; Gallen, TB; Greco, AJ; Kadowitz, PJ | 1 |
| Asano, S; Bender, SB; Borbouse, L; Bratz, IN; Dick, GM; Dincer, UD; Neeb, ZP; Payne, GA; Sturek, M; Tune, JD | 1 |
| Bryan, RM; Crossland, RF; Hartley, CJ; Lloyd, EE; Marrelli, SP; Phillips, SC; Reddy, AK; Taffet, GE | 1 |
| Alustau, MC; Barbosa-Filho, JM; Braga, VA; Figueiredo, CS; Furtado, FF; Machado, NT; Medeiros, IA; Miranda, GEC; Oliveira-Filho, AA; Queiroz, TM | 1 |
| Cao, YX; Zhang, LX; Zhang, SQ | 1 |
| Ayon, RJ; Choudhury, MS; Ko, EA; Makino, A; Smith, KA; Tang, H; Voiriot, G; Wan, J; Wang, C; Wang, J; Yamamura, A; Yuan, JX; Zimnicka, AM | 1 |
23 other study(ies) available for bay-k-8644 and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid
| Article | Year |
|---|---|
Effects of intracoronary administration of endothelin in anesthetized dogs: comparison with Bay k 8644 and U 46619.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Coronary Circulation; Coronary Vessels; Dogs; Endothelins; Female; Hemodynamics; Injections, Intra-Arterial; Male; Nitrendipine; Prostaglandin Endoperoxides, Synthetic | 1992 |
Effects of Bay K 8644 on 45Ca uptake and efflux and on contraction in the rabbit aorta.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta; Calcium; Calcium Radioisotopes; In Vitro Techniques; Nifedipine; Norepinephrine; Potassium; Prostaglandin Endoperoxides, Synthetic; Rabbits; Vasoconstriction | 1986 |
Influence of nisoldipine on vascular resistance and vasoconstrictor responses in cats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Angiotensin II; Animals; Azepines; Blood Pressure; Brimonidine Tartrate; Cardiac Output; Cats; Dinoprost; Dioxanes; Electric Stimulation; Female; Idazoxan; Male; Methoxamine; Nifedipine; Nisoldipine; Norepinephrine; Phenylephrine; Prostaglandin Endoperoxides, Synthetic; Prostaglandins F; Quinoxalines; Splanchnic Circulation; Sulfonamides; Sympathetic Nervous System; Tyramine; Vascular Resistance; Vasoconstriction | 1987 |
Blockade of thromboxane responses in the airway of the cat by SQ 29,548.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Arachidonic Acid; Arachidonic Acids; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Cats; Cytochrome P-450 Enzyme System; Dinoprost; Dose-Response Relationship, Drug; Epoprostenol; Fatty Acids, Unsaturated; Female; Hydrazines; Intramolecular Oxidoreductases; Isomerases; Male; Meclofenamic Acid; Prostaglandin D2; Prostaglandin Endoperoxides, Synthetic; Prostaglandin-E Synthases; Prostaglandins D; Prostaglandins F; Serotonin; Thromboxanes | 1987 |
Methylene blue selectively inhibits pulmonary vasodilator responses in cats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetylcholine; Angiotensin II; Animals; Blood Pressure; Bradykinin; Cats; Cyclic GMP; Epinephrine; Female; Isoproterenol; Male; Methylene Blue; Nitroglycerin; Prostaglandin Endoperoxides, Synthetic; Pulmonary Artery; Pulmonary Circulation; Reference Values; Vasodilation | 1989 |
Nisoldipine inhibits vasoconstrictor responses in the cat pulmonary vascular bed.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Animals; Azepines; Calcium Channel Blockers; Cats; Female; Male; Methoxamine; Nifedipine; Nisoldipine; Prostaglandin Endoperoxides, Synthetic; Pulmonary Circulation; Vasoconstriction; Vasodilator Agents | 1989 |
Nifedipine prevents renal injury in rats with chronic nitric oxide inhibition.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Arginine; Blood Pressure; Calcium Channel Blockers; Hemodynamics; Hypertension; In Vitro Techniques; Kidney; Kidney Glomerulus; Male; Nephritis, Interstitial; NG-Nitroarginine Methyl Ester; Nifedipine; Nitric Oxide; Norepinephrine; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Wistar; Thromboxane A2; Time Factors; Vasoconstrictor Agents | 1995 |
Cocaine sensitization of coronary artery contractions: mechanism of drug-induced spasm.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Blockers; Calcium Channels; Cattle; Cocaine; Coronary Vasospasm; Coronary Vessels; Desipramine; Electric Stimulation; In Vitro Techniques; Norepinephrine; Potassium; Prostaglandin Endoperoxides, Synthetic; Vasoconstriction | 1993 |
Evidence for uneven distribution of L-type calcium channels in rat pulmonary circulation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Blood Vessels; Calcium Channel Blockers; Calcium Channels; In Vitro Techniques; Male; Nifedipine; Potassium; Prostaglandin Endoperoxides, Synthetic; Pulmonary Circulation; Rats; Rats, Sprague-Dawley; Thromboxane A2; Tissue Distribution; Vasoconstriction; Vasoconstrictor Agents | 1995 |
Vasodilator responses to acetylcholine, bradykinin, and substance P are mediated by a TEA-sensitive mechanism.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetylcholine; Albuterol; Alprostadil; Analysis of Variance; Angiotensin II; Animals; Benzopyrans; Blood Pressure; Bradykinin; Cats; Cromakalim; Endothelium, Vascular; Female; Glyburide; Heart Rate; Hindlimb; Hydrazines; Isradipine; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitrogen Oxides; Nitroprusside; Norepinephrine; Penicillamine; Prostaglandin Endoperoxides, Synthetic; Pyrroles; S-Nitroso-N-Acetylpenicillamine; Substance P; Tetraethylammonium; Tetraethylammonium Compounds; Thromboxane A2; Vasoactive Intestinal Peptide; Vasodilation; Vasodilator Agents | 1997 |
[Pharmacological studies on alterations in contractile reactivity in aortas isolated from experimental diabetic rats].
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Endothelin-1; In Vitro Techniques; Nifedipine; Norepinephrine; Phorbol 12,13-Dibutyrate; Potassium; Protein Kinase C; Rats; Rats, Wistar; Serotonin; Staurosporine; Streptozocin; Vasoconstriction; Vasoconstrictor Agents | 1997 |
The influence of candesartan and PD123319 on responses to angiotensin II in the hindquarters vascular bed of the rat.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Calcium Channel Agonists; Dose-Response Relationship, Drug; Female; Hemodynamics; Hindlimb; Imidazoles; Injections, Intravenous; Male; Norepinephrine; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Vasoconstrictor Agents | 1999 |
Effects of PKC isozyme inhibitors on constrictor responses in the feline pulmonary vascular bed.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetophenones; Angiotensin II; Animals; Benzopyrans; Calcium Channel Agonists; Carbazoles; Cats; Drug Interactions; Enzyme Inhibitors; Female; Free Radical Scavengers; Immunohistochemistry; Indoles; Isoenzymes; Male; Muscle, Smooth, Vascular; Norepinephrine; Protein Kinase C; Protein Kinase C beta; Protein Kinase C-alpha; Pulmonary Circulation; Serotonin; Vasoconstriction; Vasoconstrictor Agents | 2001 |
Mechanism of CGRP-induced relaxation in rat intramural coronary arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Analysis of Variance; Animals; Calcitonin Gene-Related Peptide; Calcium; Calcium Channel Agonists; Charybdotoxin; Coronary Vessels; Drug Interactions; Enzyme Inhibitors; Felodipine; Fluorescent Dyes; Fura-2; Glyburide; Hypoglycemic Agents; In Vitro Techniques; Male; Osmolar Concentration; Peptides; Potassium; Potassium Channels; Rats; Rats, Sprague-Dawley; Rest; Thapsigargin; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2001 |
Disturbance of peristalsis in the guinea-pig isolated small intestine by indomethacin, but not cyclo-oxygenase isoform-selective inhibitors.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; 6-Ketoprostaglandin F1 alpha; Alprostadil; Animals; Anti-Inflammatory Agents, Non-Steroidal; Calcium Channel Agonists; Calcium Channels; Cyclic AMP; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Female; Gastrointestinal Motility; Guinea Pigs; Indomethacin; Intestine, Small; Isoenzymes; Lipoxygenase Inhibitors; Male; Peristalsis; Potassium Channels; Prostaglandin-Endoperoxide Synthases; Receptors, Thromboxane; RNA, Messenger; Vasoconstrictor Agents | 2001 |
Sites and ionic mechanisms of hypoxic vasoconstriction in frog skin.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; 4-Aminopyridine; Animals; Arterioles; Calcium Channels, L-Type; Homeostasis; Hypoxia; Mammals; Muscle, Smooth, Vascular; Nifedipine; Nitrogen; Oxygen; Potassium Channel Blockers; Skin; Time Factors; Vasoconstriction; Vasoconstrictor Agents; Venules; Xenopus laevis | 2001 |
Effects of tetrandrine on smooth muscle contraction induced by mediators in pulmonary hypertension.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Alkaloids; Angiotensin II; Animals; Antihypertensive Agents; Benzylisoquinolines; Endothelin-1; Guinea Pigs; Hypertension, Pulmonary; Male; Muscle Contraction; Muscle, Smooth, Vascular; Neuropeptide Y; Pulmonary Artery; Rats; Rats, Sprague-Dawley; SRS-A | 2002 |
Analysis of pulmonary vasodilator responses to the Rho-kinase inhibitor fasudil in the anesthetized rat.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Anesthesia; Angiotensin II; Animals; Blood Gas Analysis; Blood Pressure; Cardiac Output; Heart Rate; Hypoxia; Injections, Intravenous; Isradipine; Lung; Male; NG-Nitroarginine Methyl Ester; Protein Kinase Inhibitors; Pulmonary Circulation; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; Vascular Resistance; Vasodilator Agents | 2008 |
Impaired function of coronary BK(Ca) channels in metabolic syndrome.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 2-Chloroadenosine; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Arterioles; Benzimidazoles; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Signaling; Coronary Circulation; Coronary Vessels; Diet, Atherogenic; Disease Models, Animal; Dose-Response Relationship, Drug; Large-Conductance Calcium-Activated Potassium Channel alpha Subunits; Large-Conductance Calcium-Activated Potassium Channel beta Subunits; Large-Conductance Calcium-Activated Potassium Channels; Male; Membrane Potentials; Metabolic Syndrome; Microcirculation; Muscle, Smooth, Vascular; Mycotoxins; Nicardipine; Peptides; Phenotype; Potassium Channel Blockers; Swine; Swine, Miniature; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2009 |
Disruption of K(2P)6.1 produces vascular dysfunction and hypertension in mice.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta; Blood Pressure; Calcium Channel Agonists; Disease Models, Animal; Hypertension; Membrane Potentials; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Potassium Channels, Tandem Pore Domain; Potassium Chloride; rho-Associated Kinases; Vasoconstriction; Vasoconstrictor Agents | 2011 |
Vasorelaxation, induced by Dictyota pulchella (Dictyotaceae), a brown alga, is mediated via inhibition of calcium influx in rats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Biological Products; Calcium Channel Blockers; Calcium Channels; Dose-Response Relationship, Drug; Male; Muscle, Smooth, Vascular; Phaeophyceae; Phenylephrine; Potassium Chloride; Rats; Rats, Wistar; Tetraethylammonium; Vasodilation; Vasodilator Agents | 2011 |
Vasodilation and hypotension of CZ454, an analogue of lacidipine through inhibiting extracellular calcium influx.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Antihypertensive Agents; Blood Pressure; Caffeine; Calcium; Calcium Chloride; Calcium Signaling; Dihydropyridines; Hypotension; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Phenylephrine; Potassium; Potassium Chloride; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Vasoconstriction; Vasodilation; Vasodilator Agents | 2012 |
Chronic hypoxia selectively enhances L- and T-type voltage-dependent Ca2+ channel activity in pulmonary artery by upregulating Cav1.2 and Cav3.2.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Agonists; Calcium Channels, L-Type; Calcium Channels, T-Type; Chronic Disease; Gene Expression Regulation; Hypoxia; Male; Mesenteric Arteries; Mice; Potassium; Pulmonary Artery; Time Factors; Vasoconstrictor Agents; Vasodilation | 2013 |